Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04196530 |
| Title | BDB001-102 Open Label Dose Escalation Combination w Atezolizumab |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Birdie Biopharmaceuticals HK Limited |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Angeles Clinic | Los Angeles | California | 90025 | United States | Details | |
| Florida Cancer Specialists | Sarasota | Florida | 34230 | United States | Details | |
| Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| South Texas Accelerated Research Therapeutics (START) | San Antonio | Texas | 78229 | United States | Details |